Genomic characterisation of clinically significant blood group variants in Aboriginal Australians.


Journal

Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479

Informations de publication

Date de publication:
11 Mar 2024
Historique:
received: 28 09 2023
accepted: 24 01 2024
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 1 4 2024
Statut: aheadofprint

Résumé

Hematological disorders are often treated with blood transfusions. Many blood group antigens and variants are population-specific, and for patients with rare blood types, extensive donor screening is required to find suitable matches for transfusion. There is a scarcity of knowledge regarding blood group variants in Aboriginal Australian populations, despite a higher need for transfusion due to the higher prevalence of renal diseases and anaemia. In this study, we applied next-generation sequencing and analysis to 245 samples obtained from Aboriginal Australians from South-East Queensland, to predict antigen phenotypes for 36 blood group systems. We report potential weak antigens in blood group systems RH, FY and JR that have potential clinical implications in transfusion and pregnancy settings. These include partial DIII type 4, weak D type 33, and Del RHD (IVS2-2delA). The rare Rh phenotypes D+ C+ E+ c- e+ and D+ C+ E+ c+ e- were also detected. The comprehensive analyses of blood group genetic variant profiles identified in this study will provide insight and an opportunity to improve Aboriginal health by aiding in the identification of appropriate blood products for population-specific transfusion needs.

Sections du résumé

BACKGROUND BACKGROUND
Hematological disorders are often treated with blood transfusions. Many blood group antigens and variants are population-specific, and for patients with rare blood types, extensive donor screening is required to find suitable matches for transfusion. There is a scarcity of knowledge regarding blood group variants in Aboriginal Australian populations, despite a higher need for transfusion due to the higher prevalence of renal diseases and anaemia.
MATERIALS AND METHODS METHODS
In this study, we applied next-generation sequencing and analysis to 245 samples obtained from Aboriginal Australians from South-East Queensland, to predict antigen phenotypes for 36 blood group systems.
RESULTS RESULTS
We report potential weak antigens in blood group systems RH, FY and JR that have potential clinical implications in transfusion and pregnancy settings. These include partial DIII type 4, weak D type 33, and Del RHD (IVS2-2delA). The rare Rh phenotypes D+ C+ E+ c- e+ and D+ C+ E+ c+ e- were also detected.
DISCUSSION CONCLUSIONS
The comprehensive analyses of blood group genetic variant profiles identified in this study will provide insight and an opportunity to improve Aboriginal health by aiding in the identification of appropriate blood products for population-specific transfusion needs.

Identifiants

pubmed: 38557323
pii: BloodTransfus.664
doi: 10.2450/BloodTransfus.664
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Sudhir Jadhao (S)

Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, Australia.
Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Australia.

Candice Davison (C)

Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Australia.

Eileen Roulis (E)

Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Australia.

Simon Lee (S)

Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, Australia.

Tamika Campbell (T)

Carbal Medical Services, Toowoomba, Australia.

Reece Griffin (R)

Carbal Medical Services, Toowoomba, Australia.

Maree Toombs (M)

School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.

Alex Brown (A)

National Centre for Indigenous Genomics, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
Indigenous Genomics, Telethon Kids Institute, Adelaide, Australia.

Maree Perry (M)

Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Australia.

Bushra Nasir (B)

Rural Clinical School, Faculty of Medicine, The University of Queensland, Toowoomba, Australia.

David O Irving (DO)

Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Australia.
University of Technology, Sydney, Australia.

Catherine A Hyland (CA)

Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Australia.

Robert L Flower (RL)

Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Australia.

Shivashankar H Nagaraj (SH)

Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, Australia.
Translational Research Institute, Brisbane, Australia.

Classifications MeSH